Interacoustics is happy to introduce the Audible Contrast Threshold (ACT™) test; a new, diagnostic test to support the number one challenge with hearing loss: difficulty hearing speech in background noise.
Grow your own business, look after your private and NHS customers, serve your community, create an asset for your family’s future and enjoy the profits of all your hard work.
C2Dx Inc., a medical device company based in the U.S., has acquired the otolaryngology/head and neck surgery (“OHNS”) family of products from Cook Medical.
BIOHIT HealthCare is excited to announce an upcoming webinar on the Current and future trends in inflammatory bowel disease (IBD) therapeutic drug monitoring (TDM).